TETRAKIS(TRIPHENYLACETATO)DIRHODIUM(II) – (68803-79-2)

ABT-724, 70006-24-5, ABT 724, 2-[(4-pyridin-2-ylpiperazin-1-yl)methyl]-1H-benzimidazole, 2-((4-(pyridin-2-yl)piperazin-1-yl)methyl)-1H-benzo[d]imidazole, 4WV2575JWT, CHEMBL440687, 2-[(4-pyridin-2-ylpiperazin-1-yl)methyl]-1H-benzimidazole trihydrochloride, A-369724, 1H-Benzimidazole, 2-((4-(2-pyridinyl)-1-piperazinyl)methyl)-, 2-{[4-(pyridin-2-yl)piperazin-1-yl]methyl}-1H-1, 3-benzodiazole, ABT724, UNII-4WV2575JWT, MLS001233669, SCHEMBL1448486, CHEBI:104134, FRPJGTNLZNXQEX-UHFFFAOYSA-N, 2-((4-Pyridin-2-ylpiperazine-1-yl)methyl)-1H-benzimidazole, ABT 724 ABT724, DTXSID001025592, HMS2888K18, KUC105568N, BCP33290, EX-A7270, BDBM50145075, AKOS015994554, ES-0001, KSC-15-042, 474417-17-9, HY-14330, SMR000592214, DB-014691, CS-0003286, D80748, EN300-1700029, SR-01000050272, Q4650426, SR-01000050272-1, BRD-K37714784-305-01-3, BRD-K37714784-305-02-1, Z55621861, 2-(4-Pyridin-2-yl-piperazin-1-ylmethyl)-1H-benzoimidazole, 2-((4-(2-Pyridinyl)-1-piperazinyl)methyl)-1H-benzimidazole, 2-((4-(PYRIDIN-2-YL)PIPERAZIN-1-YL)METHYL)-1H-BENZIMIDAZOLE